Liver/Biliary Disorders News

An analysis of the global online conversations of more than 1,600 healthcare professionals has revealed celebration at news of the approval of the first treatment for adults with metabolic dysfunction-associated steatohepatitis.

Food insecurity was associated with lower odds of metabolic dysfunction-associated steatotic liver disease among patients with HIV, although the presence of diabetes increased the odds of fibrosis in this population, according to data.

Recipients of livers recovered by normothermic regional perfusion vs. standard super rapid recovery experienced lower rates of ischemic cholangiopathy and biliary complications, with comparable patient and graft survival, data showed.

Hepatic adverse events with bimekizumab were low and consistent through 2 years of treatment among patients with moderate to severe psoriasis, according to a study.

April is Alcohol Awareness Month, an annual campaign intended to boost awareness of the heavy burden that alcohol misuse places on affected individuals and their families, as well as its adverse impact on their health and society.

Didn’t make it to the meeting? Here’s a collection of Healio-curated highlights, including expert insight on the latest research and treatments for biliary diseases, including primary biliary cholangitis, progressive familial cholestasis and more.

Vibration-controlled transient elastography-based Agile scores accurately predicted liver-related events in patients with metabolic dysfunction-associated steatotic liver disease and “may be suitable alternatives” to routine liver biopsy.

In this video, Sarah L. Maxwell, MD, and Janet M. Wojcicki, PhD, MPH, discuss a reported link between food insecurity at age 4 years and an increased risk for metabolic dysfunction-associated steatotic liver disease among Latino children.

Daily low-dose aspirin “significantly reduced” hepatic fat quantity at 6 months compared with placebo among patients with metabolic dysfunction-associated steatotic liver disease, according to preliminary trial results published in JAMA.

While the CDC estimated that excessive alcohol use contributed to approximately 178,000 U.S. deaths each year from 2020 to 2021, an emerging lifestyle trend may help counter those statistics in the years ahead.